https://www.zacks.com/commentary/2221807/earnings-season-scorecard-and-analyst-reports-for-thermo-fisher-philip-morris-general-dynamics?cid=CS-ZC-FT-research_daily-2221807
Feb 06, 2024 - Today's Research Daily features the real-time earnings season scorecard and updated analyst reports on Thermo Fisher (TMO), Philip Morris International (PM) and General Dynamics (GD).
zc:6024281491119759963
0
https://www.fool.com/earnings/call-transcripts/2024/01/31/thermo-fisher-scientific-tmo-q4-2023-earnings-call/?source=iedfolrf0000001
Jan 31, 2024 - TMO earnings call for the period ending December 31, 2023.
0
fool:5625968671959640194
0
https://www.zacks.com/stock/news/2212501/thermo-fisher-scientific-tmo-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2212501
Jan 18, 2024 - In the latest trading session, Thermo Fisher Scientific (TMO) closed at $544.42, marking a +0.96% move from the previous day.
zc:-7808744626364993405
0
https://www.zacks.com/stock/news/2210929/what-s-in-store-for-thermo-fisher-tmo-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2210929
Jan 16, 2024 - Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and the latest strategic pacts.
zc:-2354810804236870659
0
https://www.zacks.com/stock/news/2205963/thermo-fisher-scientific-tmo-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2205963
Jan 04, 2024 - Thermo Fisher Scientific (TMO) closed the most recent trading day at $537.36, moving +1.61% from the previous trading session.
zc:1199644087444309171
0
https://www.zacks.com/stock/news/2205808/select-medical-sem-unveils-separation-plan-for-concentra?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2205808
Jan 04, 2024 - Select Medical (SEM) intends to separate its Concentra business in a bid to enhance shareholder value and boost growth prospects of strategically prioritized areas.
zc:743460894245056112
0
https://www.zacks.com/stock/news/2205062/thermo-fisher-tmo-end-markets-drive-growth-amid-macro-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2205062
Jan 03, 2024 - In the academic and government end markets, Thermo Fisher (TMO) is delivering strong growth in the electron microscopy, chromatography and mass spectrometry businesses.
zc:7091387489878123723
0
https://www.zacks.com/stock/news/2199299/thermo-fisher-tmo-to-allocate-ifa-testing-kits-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199299
Dec 18, 2023 - Thermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics.
zc:2911667716578505357
0
https://www.zacks.com/stock/news/2196649/thermo-fisher-tmo-launches-new-solutions-for-clinical-labs?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196649
Dec 12, 2023 - Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.
zc:1729546456007571133
0
https://www.zacks.com/stock/news/2192709/thermo-fisher-tmo-advances-health-equity-via-new-partnership?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192709
Dec 04, 2023 - Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.
zc:-6189043047275391729
0